Dermatology (Basel, Switzerland) · 1998
PUVA treatment for alopecia areata. Experience in a Turkish population.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sahin S, Yalçin B, Karaduman A
Аннотация
BACKGROUND: PUVA has been suggested as an alternative treatment modality for resistant, diffuse alopecia areata (AA). However, there are conflicting reports on its efficacy.
OBJECTIVE: The aim of this study was to investigate the efficacy of PUVA treatment of AA in a Turkish population.
METHODS: Twenty-four patients (15 female and 9 male) suffering from extensive AA for more than 1 year were included in a retrospective study. PUVA was administered to the whole body 3 times a week. Only 75-100% hair regrowth was defined as cosmetically acceptable.
RESULTS: Excellent hair regrowth was achieved in 37.5% of the patients. The therapeutic efficiency was not related to age and sex of the patients, duration and extent of the disease (p <0. 05).
CONCLUSION: PUVA can be an alternative therapy for patients with extensive AA independently of the duration of disease.
OBJECTIVE: The aim of this study was to investigate the efficacy of PUVA treatment of AA in a Turkish population.
METHODS: Twenty-four patients (15 female and 9 male) suffering from extensive AA for more than 1 year were included in a retrospective study. PUVA was administered to the whole body 3 times a week. Only 75-100% hair regrowth was defined as cosmetically acceptable.
RESULTS: Excellent hair regrowth was achieved in 37.5% of the patients. The therapeutic efficiency was not related to age and sex of the patients, duration and extent of the disease (p <0. 05).
CONCLUSION: PUVA can be an alternative therapy for patients with extensive AA independently of the duration of disease.